Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Mantle Cell Lymphoma: early-phase trial registry
46 of 103 indexed Mantle Cell Lymphoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #130 of 28,707 conditions by registered trial count.
103 US clinical trials · 46 currently recruiting · #130 of 28,707 conditions by registered trial count
Mantle Cell Lymphoma: 103 US clinical trials tracked, 46 recruiting.
Mantle Cell Lymphoma is the subject of 103 registered US clinical trials on ClinicalTrials.gov, 46 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 86 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 12 of these trials.
Enrollment posture brief
Registry condition mantle-cell-lymphoma
OPEN 46 | RECR 45% | LATE 7 | EARLY 86 | RANK #130 | SPON 12
Volume-matched condition peers
Nearest open-share peer: Food Insecurity (45% recruiting · 38 trials)
Mantle Cell Lymphoma lists 46 open slots (45% of 103 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Mantle Cell Lymphoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Mantle Cell Lymphoma is recruiting above its size-band peers.
46 of 103 indexed trials (44.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Mantle Cell Lymphoma trials is spread across many organizations.
M.D. Anderson Cancer Center accounts for 12 of 103 trials (11.7%). 71 distinct sponsors appear on at least one study for this condition label.
-
Most Mantle Cell Lymphoma trials plan to enrol fewer than 100 people.
Median target enrolment is 43 among the 103 trials that report a genuine target (sentinel values excluded). 73 of those (70.9%) plan for fewer than 100 participants.
-
Mantle Cell Lymphoma research is mostly interventional.
96 interventional and 7 observational studies make up this index (93.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
103 total, page 3 of 3
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
NCT01184885
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
TCR2 Therapeutics
NCT04323657
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
Anand Jillella
NCT01504776
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 46 |
| Phase 2 | 40 |
| Phase 3 | 7 |
Top Sponsors
Named interventions
Most-linked intervention names on Mantle Cell Lymphoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Mantle Cell Lymphoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Mantle Cell Lymphoma page
103 registered trials, 46 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 46 Mantle Cell Lymphoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Mantle Cell Lymphoma trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mantle Cell Lymphoma condition card totals 103 registered trials; most-linked intervention Rituximab; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.